{
    "organizations": [],
    "uuid": "3ccb6cd560e2a28b3a49397f1c9d765a0746925d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-interpace-diagnostics-announces-ad/brief-interpace-diagnostics-announces-additional-coverage-of-thyroid-tests-idUSFWN1QQ0UM",
    "ord_in_thread": 0,
    "title": "BRIEF-Interpace Diagnostics Announces Additional Coverage of Thyroid Tests",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Interpace Diagnostics Group Inc :\n* INTERPACE DIAGNOSTICS - 4 ADDITIONAL BLUE CROSS BLUE SHIELD PLANS AGREED TO COVER BOTH OF INTERPACEâ€™S PROPRIETARY THYROID TESTS, THYGENX AND THYRAMIR Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T21:16:00.000+02:00",
    "crawled": "2018-03-09T14:41:59.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "interpace",
        "diagnostics",
        "group",
        "inc",
        "interpace",
        "diagnostics",
        "additional",
        "blue",
        "cross",
        "blue",
        "shield",
        "plan",
        "agreed",
        "cover",
        "interpace",
        "proprietary",
        "thyroid",
        "test",
        "thygenx",
        "thyramir",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}